Australian Healthtech Stock News

The recent departure of director Catherine West from Nine Entertainment Holdings (ASX:NEC) is drawing attention as it represents a new chapter in the company’s board composition. This change may potentially affect governance and stakeholder alignment. See our latest analysis for Nine Entertainment Holdings. Beyond the boardroom news, Nine Entertainment Holdings’ shares have faced headwinds lately, with a 30-day share price return of -8.26% and a 90-day drop of nearly 33%. However, the company...

Harvey Norman Holdings (ASX:HVN) has announced a new share repurchase program, authorizing the buyback of up to 10% of its issued capital over the next year. This move often signals confidence from management in the company’s outlook. See our latest analysis for Harvey Norman Holdings. Harvey Norman Holdings’ share price has surged more than 56% year-to-date, with momentum especially strong over the past three months. This positive trend, echoed by a robust one-year total shareholder return...

Core Lithium recently announced an updated reopening plan for the Finniss Project, deferring the transition to underground mining and cutting pre-production costs by A$35 million to A$45 million, while also increasing the ore reserve estimate for the Grants deposit by 33%. This development enhances the project's appeal for funding partners and aligns with stronger global demand for battery-grade lithium, supported by recent strength in lithium prices. We'll explore how the ore reserve...

ANZ Group Holdings (ASX:ANZ) has just announced its full-year results, showing a dip in profit following settlement and restructuring charges. Despite this, the Board confirmed a final dividend and highlighted higher net interest income. See our latest analysis for ANZ Group Holdings. Despite the headline dip in annual profit, ANZ Group Holdings has kept the market’s attention with its ongoing strategic updates, board-backed dividend plans, and transparent governance releases. Interestingly,...

At its Annual General Meeting on November 11, 2025, Coles Group reported operational progress in automation, supply chain improvements, and digital expansion under new Chairman Peter Allen and CEO Leah Weckert, while shareholders approved routine resolutions but did not pass a constitutional amendment. An interesting aspect is Coles’ focus on technology-driven efficiency and product innovation, exemplified by expanded exclusive ranges and increased eCommerce sales, signaling ongoing efforts...

Key Insights Evolution Mining's Annual General Meeting to take place on 20th of November CEO Lawrie Conway's total...

Key Insights Bellevue Gold's Annual General Meeting to take place on 20th of November Total pay for CEO Darren Stralow...

Key Insights New Hope will host its Annual General Meeting on 20th of November CEO Rob Bishop's total compensation...

Key Insights Sonic Healthcare will host its Annual General Meeting on 20th of November Salary of AU$2.37m is part of...

Key Insights IPH's Annual General Meeting to take place on 20th of November Salary of AU$1.38m is part of CEO Andrew...

Key Insights Significant control over REA Group by public companies implies that the general public has more power to...

Karoon Energy (ASX:KAR) has just announced Ms Carri Lockhart as its new Chief Executive Officer and Managing Director. This marks a key leadership change that could influence the company’s next phase of strategy and performance. See our latest analysis for Karoon Energy. Karoon Energy’s latest executive shake-up comes as investors refocus on momentum in the share price. With a strong 1-day return of 4.43% and a 1-year total shareholder return of nearly 29%, recent gains suggest the market is...

As the Australian market experiences a cautious optimism amid ongoing global economic uncertainties, investors are keeping a close eye on potential opportunities. Penny stocks, often seen as relics of past speculative fervor, continue to offer intriguing possibilities for those willing to explore smaller or newer companies with strong financial health. With this in mind, we'll examine several penny stocks that could offer both value and growth potential in today's ever-evolving market landscape.

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Investors who take an interest in Dicker Data Limited ( ASX:DDR ) should definitely note that the COO & Executive...

On October 31, 2025, Cobram Estate Olives Limited announced an increase to its annual cash dividend to A$0.045 per share, with an ex-dividend date of November 6, 2025, and payment scheduled for November 28, 2025. This dividend increase reflects management's confidence in the company's performance and may draw fresh attention from income-focused investors. We'll assess how the higher dividend payout shapes Cobram Estate Olives' investment narrative and signals potential management...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Earlier this week, Silex Systems Limited released a new presentation outlining its ongoing and future plans for the commercialization of its third-generation SILEX laser uranium enrichment technology in collaboration with Global Laser Enrichment. This update highlights Silex Systems' ambition to strengthen its position in the nuclear technology sector by advancing innovative enrichment solutions through their partnership. We'll now explore how commercialization progress of the SILEX laser...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Key Insights Galan Lithium's significant individual investors ownership suggests that the key decisions are influenced...

VEEM Ltd ( ASX:VEE ) shareholders might be concerned after seeing the share price drop 22% in the last month. But don't...

Atlas Arteria (ASX:ALX) has announced a major overhaul of its executive team, reducing the number of leaders from six to four and broadening each role’s responsibilities to better support the company’s strategic priorities. See our latest analysis for Atlas Arteria. Recent executive changes signal Atlas Arteria’s renewed push for efficiency, and the market seems to have taken notice. The company has seen a 7.1% 30-day share price return after a period of softer momentum earlier this year...

With a price-to-sales (or "P/S") ratio of 3.5x Alcidion Group Limited ( ASX:ALC ) may be sending very bullish signals...